Detalhe da pesquisa
1.
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Br J Haematol
; 178(2): 250-256, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419413
2.
Synchronous dual hematological malignancies: new or underreported entity?
Hematology
; 23(9): 596-599, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29874974
3.
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.
J Thorac Oncol
; 7(3): 579-86, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198426